Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""EOSINOPHILIA"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 19023
Tytuł:
Juvenile eosinophilic fasciitis: a single center case series.
Autorzy:
Stubbs LA; Department of Pediatrics, Division of Rheumatology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Ogunbona O; Department of Pathology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.; Department of Pathology and Genomic Medicine, Houston Methodist, Houston, TX, USA.
Beil E; Department of Pediatrics, Division of Rheumatology, Texas Children's Hospital, Feigin Tower, 1102 Bates, Ste. 330, Houston, TX, TX 77030, USA.
Szafron V; Department of Pediatrics, Division of Allergy and Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Adesina A; Department of Pathology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Anvari S; Department of Pediatrics, Division of Allergy and Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Lai J; Department of Pediatrics, Division of Rheumatology, Texas Children's Hospital, Feigin Tower, 1102 Bates, Ste. 330, Houston, TX, TX 77030, USA.
Ramirez A; Department of Pediatrics, Division of Rheumatology, Texas Children's Hospital, Feigin Tower, 1102 Bates, Ste. 330, Houston, TX, TX 77030, USA.
Ditzler MG; Department of Radiology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
DeGuzman M; Department of Pediatrics, Division of Rheumatology, Texas Children's Hospital, Feigin Tower, 1102 Bates, Ste. 330, Houston, TX, TX 77030, USA. .
Pokaż więcej
Źródło:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 Feb 24; Vol. 22 (1), pp. 29. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Fasciitis*/diagnosis
Fasciitis*/drug therapy
Fasciitis*/complications
Eosinophilia*/diagnosis
Eosinophilia*/drug therapy
Eosinophilia*/complications
Adult ; Humans ; Child ; Female ; Adolescent ; Child, Preschool ; Male ; Diagnosis, Differential ; Methotrexate/therapeutic use
SCR Disease Name:
Eosinophilic Fasciitis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Kimura's disease: a case report.
Autorzy:
Anbessie ZM; Bethzatha General Hospital, 57060, Addis Ababa, Ethiopia. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Feb 06; Vol. 18 (1), pp. 44. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Kimura Disease*/diagnosis
Angiolymphoid Hyperplasia with Eosinophilia*/diagnosis
Angiolymphoid Hyperplasia with Eosinophilia*/drug therapy
Angiolymphoid Hyperplasia with Eosinophilia*/pathology
Lymphadenopathy*
Male ; Humans ; Adult ; Neoplasm Recurrence, Local ; Prednisolone/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Retinoid orphan receptor gamma t (rorγt) promotes inflammatory eosinophilia but is dispensable for innate immune-mediated colitis.
Autorzy:
Torres-Huerta A; Department of Microbiology & Immunology, Indiana University School of Medicine-South Bend, South Bend, IN, United States of America.
Ruley-Haase K; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Reed T; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Boger-May A; Department of Microbiology & Immunology, Indiana University School of Medicine-South Bend, South Bend, IN, United States of America.
Rubadeux D; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Mayer L; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Rajashekara AM; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Hiller M; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Frech M; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Roncagli C; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Pedersen C; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Camacho MC; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Hollmer L; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
English L; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Kane G; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Boone DL; Department of Microbiology & Immunology, Indiana University School of Medicine-South Bend, South Bend, IN, United States of America.; Department of Biology, University of Notre Dame, South Bend, IN, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 21; Vol. 19 (3), pp. e0300892. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Colitis*
Inflammatory Bowel Diseases*/metabolism
Eosinophilia*/metabolism
Anti-Infective Agents*/metabolism
Mice ; Animals ; Immunity, Innate ; Lymphocytes/metabolism ; Nuclear Receptor Subfamily 1, Group F, Member 3/genetics ; Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism ; Inflammation/metabolism ; Intestinal Mucosa/metabolism ; Retinoids ; Mice, Inbred C57BL
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Repeated sensitization of mice with microfilariae of Litomosoides sigmodontis induces pulmonary eosinophilia in an IL-33-dependent manner.
Autorzy:
Lenz B; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
Ehrens A; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), partner site Bonn-Cologne, Bonn, Germany.
Ajendra J; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
Risch F; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
Gal J; Unité Molécules de Communication et Adaptation des Microorganismes (MCAM, UMR 7245), Equipe Parasites et Protistes Libres, Muséum National d'Histoire Naturelle, CNRS; CP52, Paris, France.
Neumann AL; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
Reichwald JJ; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
Strutz W; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.
McSorley HJ; Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Martin C; Unité Molécules de Communication et Adaptation des Microorganismes (MCAM, UMR 7245), Equipe Parasites et Protistes Libres, Muséum National d'Histoire Naturelle, CNRS; CP52, Paris, France.
Hoerauf A; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), partner site Bonn-Cologne, Bonn, Germany.
Hübner MP; Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), partner site Bonn-Cologne, Bonn, Germany.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Mar 08; Vol. 20 (3), pp. e1012071. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Eosinophilia*
Filariasis*/parasitology
Filarioidea*/physiology
Asthma*
Humans ; Animals ; Mice ; Microfilariae ; Immunity, Innate ; Interleukin-33 ; Lymphocytes/pathology ; Eosinophils ; Mice, Inbred BALB C
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
TNF Superfamily and ILC2 Activation in Asthma.
Autorzy:
Matsuyama T; Respiratory Research Group, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.; Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.
Salter BM; Respiratory Research Group, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
Emami Fard N; Respiratory Research Group, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
Machida K; Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.
Sehmi R; Respiratory Research Group, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Feb 29; Vol. 14 (3). Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Asthma*
Pulmonary Eosinophilia*
Humans ; Immunity, Innate ; Lymphocytes/metabolism ; Cytokines/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Eosinophils of patients with localized and diffuse cutaneous leishmaniasis: Differential response to Leishmania mexicana, with insights into mechanisms of damage inflicted upon the parasites by eosinophils.
Autorzy:
Salaiza-Suazo N; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Porcel-Aranibar R; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Cañeda-Guzmán IC; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Ruiz-Remigio A; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Zamora-Chimal J; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Delgado-Domínguez J; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Cervantes-Sarabia R; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Carrada-Figueroa G; División Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabasco (UJAT), Tabasco, México.
Sánchez-Barragán B; Escuela de Medicina, Universidad Juárez Autónoma de Tabasco (UJAT), Tabasco, México.
Leal-Ascencio VJ; Hospital Regional de Alta Especialidad Dr. Juan Graham, Secretaría de Salud del Estado de Tabasco, Villahermosa, Tabasco, México.
Pérez-Torres A; Departamento de Biología Celular y Tisular, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.
Rodríguez-Martínez HA; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Becker I; Facultad de Medicina, Unidad de Investigación en Medicina Experimental, Universidad Nacional Autónoma de México, Ciudad de México, México.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 15; Vol. 19 (2), pp. e0296887. Date of Electronic Publication: 2024 Feb 15 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Leishmaniasis, Diffuse Cutaneous*
Leishmania mexicana*
Parasites*
Leishmaniasis, Cutaneous*
Eosinophilia*
Animals ; Humans ; Eosinophils ; Disease Progression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification and characterization of a novel nematode pan allergen (NPA) from Wuchereria bancrofti and their potential role in human filarial tropical pulmonary eosinophilia (TPE).
Autorzy:
Katru SC; Department of Biomedical Sciences, University of Illinois, College of Medicine Rockford, Rockford, IL, United States of America.
Balakrishnan AS; Department of Biomedical Sciences, University of Illinois, College of Medicine Rockford, Rockford, IL, United States of America.
Munirathinam G; Department of Biomedical Sciences, University of Illinois, College of Medicine Rockford, Rockford, IL, United States of America.
Hadadianpour A; Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, A2210 Medical Center North, Nashville, Tennessee, United States of America.
Smith SA; Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, A2210 Medical Center North, Nashville, Tennessee, United States of America.
Kalyanasundaram R; Department of Biomedical Sciences, University of Illinois, College of Medicine Rockford, Rockford, IL, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Feb 14; Vol. 18 (2), pp. e0011972. Date of Electronic Publication: 2024 Feb 14 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Pulmonary Eosinophilia*/parasitology
Elephantiasis, Filarial*
Animals ; Humans ; Wuchereria bancrofti/genetics ; Allergens/genetics ; Microfilariae ; Immunoglobulin E
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis.
Autorzy:
Yadavalli CS; Department of Medicine, Section of Pulmonary Diseases, Tulane Eosinophilic Disorder Center, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Upparahalli Venkateshaiah S; Department of Medicine, Section of Pulmonary Diseases, Tulane Eosinophilic Disorder Center, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Verma AK; Division of Gastroenterology, Cincinnati Childrens Medical Center, Cincinnati, OH 45229, USA.
Kathera C; Department of Medicine, Section of Pulmonary Diseases, Tulane Eosinophilic Disorder Center, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Duncan PS; Division of Gastroenterology, School of Medicine, Tulane University, New Orleans, LA 70118, USA.
Vaezi M; Division of Gastroenterology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Paul RJ; Division of Physiology, Cincinnati University, Cincinnati, OH 45220, USA.
Mishra A; Department of Medicine, Section of Pulmonary Diseases, Tulane Eosinophilic Disorder Center, School of Medicine, Tulane University, New Orleans, LA 70112, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2024 Feb 06; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Eosinophilic Esophagitis*/drug therapy
Eosinophilic Esophagitis*/pathology
Enteritis*
Eosinophilia*
Gastritis*
Humans ; Animals ; Mice ; Eosinophils ; Receptors, Vasoactive Intestinal Peptide ; Mast Cells/pathology ; Interleukin-13 ; Vasoactive Intestinal Peptide
SCR Disease Name:
Eosinophilic enteropathy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and Pathological Correlation in Concomitant Celiac Disease and Eosinophilic Esophagitis Suggests Separate Etiologies.
Autorzy:
Castrodad-Rodríguez CA; Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
Cheng J; Department of Pathology, The University of Michigan School of Medicine, Ann Arbor, MI, USA.
Westerhoff M; Department of Pathology, The University of Michigan School of Medicine, Ann Arbor, MI, USA.
Liang GH; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
Lin J; Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
Nalbantoglu I; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
Hu S; Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.
Sekhri R; Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
Panarelli NC; Department of Pathology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 27-34. Date of Electronic Publication: 2023 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Eosinophilic Esophagitis*/complications
Eosinophilic Esophagitis*/diagnosis
Eosinophilic Esophagitis*/pathology
Celiac Disease*/complications
Celiac Disease*/pathology
Enteritis*
Eosinophilia*
Gastritis*
Humans ; Duodenum/pathology
SCR Disease Name:
Eosinophilic enteropathy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An 8-year follow-up of IgG4-related skin disease presented with generalized ALHE-like eruptions: successful treatment of glucocorticoid and cyclophosphamide.
Autorzy:
Wang G; Department of Dermatology, Peking University Third Hospital, Beijing, China.
Tu P; Department of Dermatology, Peking University First Hospital, Beijing, China.
Su J; Department of Pathology, Peking University Third Hospital, Beijing, China.
Wu W; Department of Dermatology, Peking University Third Hospital, Beijing, China.
Zhang C; Department of Dermatology, Peking University Third Hospital, Beijing, China.
Wang W; Department of Dermatology, Peking University Third Hospital, Beijing, China.
Li W; Department of Dermatology, Peking University Third Hospital, Beijing, China.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2279899. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Angiolymphoid Hyperplasia with Eosinophilia*/pathology
Angiolymphoid Hyperplasia with Eosinophilia*/therapy
Immunoglobulin G4-Related Disease*/complications
Humans ; Male ; Middle Aged ; Cyclophosphamide/therapeutic use ; Follow-Up Studies ; Glucocorticoids/therapeutic use ; Immunoglobulin G
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful Management of Refractory Kimura Disease with CVP Chemotherapy: A Case Report.
Autorzy:
Heo J; Department of Ophthalmology, Pusan National University College of Medicine, Busan, South Korea.
Choi HY; Department of Ophthalmology, Pusan National University College of Medicine, Busan, South Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.
Park J; Department of Ophthalmology, Pusan National University College of Medicine, Busan, South Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Jan 29; Vol. 25, pp. e942753. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Kimura Disease*/drug therapy
Angiolymphoid Hyperplasia with Eosinophilia*/diagnosis
Angiolymphoid Hyperplasia with Eosinophilia*/drug therapy
Angiolymphoid Hyperplasia with Eosinophilia*/pathology
Female ; Humans ; Middle Aged ; Prednisone/therapeutic use ; Vincristine/therapeutic use ; Adrenal Cortex Hormones/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Eosinophilic enterocolitis: a case report.
Autorzy:
Smaoui H; Mongi Slim University Hospital, Tunis, Tunisia. .
Nakhli A; Mongi Slim University Hospital, Tunis, Tunisia.
Hemdani N; Mongi Slim University Hospital, Tunis, Tunisia.
Bouchabou B; Mongi Slim University Hospital, Tunis, Tunisia.
Ennaifer R; Mongi Slim University Hospital, Tunis, Tunisia.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Jan 19; Vol. 18 (1), pp. 22. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Enterocolitis*/diagnosis
Colitis*/diagnosis
Eosinophilia*/diagnosis
Eosinophilia*/drug therapy
Eosinophilia*/pathology
Male ; Humans ; Adult ; Colonoscopy ; Intestine, Small/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular Diagnosis of Severe Angiostrongylus cantonensis-Induced Eosinophilic Meningitis: A Case Report Emphasizing the Need for Accurate Detection Methods.
Autorzy:
Luo WT; Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsu CH; Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Wu RC; Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chen HP; Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Dec 04; Vol. 24, pp. e941925. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Angiostrongylus cantonensis*
Eosinophilia*/diagnosis
Eosinophilia*/parasitology
Meningitis*/diagnosis
Meningitis*/therapy
Aged ; Animals ; Humans ; Male ; Dexamethasone/therapeutic use ; Leukocytosis
SCR Disease Name:
Angiostrongyliasis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient.
Autorzy:
Zhang S; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China.
Lu L; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China.
Feng J; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China.
Hu Z; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China.
Song H; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China.
Yang L; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China.
Liu Y; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China.
Chen D; Department of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, P.R. China.
Wang T; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, P.R. China.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2229466.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Dermatitis, Atopic*/drug therapy
Uveitis*/chemically induced
Uveitis*/drug therapy
Eosinophilia*/chemically induced
Eosinophilia*/drug therapy
Humans ; Female ; Adult ; Antibodies, Monoclonal, Humanized/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment of Vulvar Angiolymphoid Hyperplasia with Eosinophilia with Topical Corticosteroids.
Autorzy:
Fazil Jaber N; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden.
Krynitz B; Division of Pathology, Department of Oncology-Pathology (Solna), Karolinska Institutet, Sweden; Department of Pathology and Cancer Diagnostics (Solna), Karolinska University Laboratories, Sweden.
Curman P; Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden; Dermatology and Venereology Division, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło:
Acta dermato-venereologica [Acta Derm Venereol] 2023 Nov 20; Vol. 103, pp. adv19659. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Angiolymphoid Hyperplasia with Eosinophilia*/diagnosis
Angiolymphoid Hyperplasia with Eosinophilia*/drug therapy
Leukocyte Disorders*
Castleman Disease*
Humans ; Adrenal Cortex Hormones/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Role of eosinophilia in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab: Prediction of immune-related adverse events and favorable outcome.
Autorzy:
Ueki Y; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Ohshima S; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Omata J; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yokoyama Y; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Takahashi T; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Shodo R; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yamazaki K; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Horii A; Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Nov; Vol. 12 (22), pp. 20810-20820. Date of Electronic Publication: 2023 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Antineoplastic Agents, Immunological*/adverse effects
Eosinophilia*
Head and Neck Neoplasms*/drug therapy
Humans ; Nivolumab/adverse effects ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/chemically induced ; Neoplasm Recurrence, Local/drug therapy ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical effects of dupilumab: A novel treatment for Kimura disease.
Autorzy:
Shang BS; Department of Pediatrics, Chung Shan Medical University Hospital, Taichung City, Taiwan.; Department of Medicine, Chung Shan Medical University, Taichung City, Taiwan.; Institute of Medicine, Chung Shan Medical University Hospital, Taichung City, Taiwan.
Hsiao CH; Department of Pediatrics, Cheng Ching Hospital, Taichung City, Taiwan.
Tsao TF; Department of Medicine, Chung Shan Medical University, Taichung City, Taiwan.; Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung City, Taiwan.
Liao YY; Department of Medicine, Chung Shan Medical University, Taichung City, Taiwan.; Department of Surgery, Chung Shan Medical University Hospital, Taichung City, Taiwan.
Lin WL; Department of Pathology, Chung Shan Medical University Hospital, Taichung City, Taiwan.; Department of Pathology, Chung Shan Medical University, Taichung City, Taiwan.
Lee WI; Department of Pediatrics, Division of Allergy, Asthma, Immunology and Rheumatology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan.; Primary Immunodeficiency Care and Research Institute, Chang Gung University College of Medicine and Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Lue KH; Department of Pediatrics, Chung Shan Medical University Hospital, Taichung City, Taiwan.; Department of Medicine, Chung Shan Medical University, Taichung City, Taiwan.; Department of Biological Science & Technology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Pokaż więcej
Źródło:
Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Nov; Vol. 11 (11), pp. e1084.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Kimura Disease*/complications
Kimura Disease*/drug therapy
Angiolymphoid Hyperplasia with Eosinophilia*/diagnosis
Angiolymphoid Hyperplasia with Eosinophilia*/drug therapy
Angiolymphoid Hyperplasia with Eosinophilia*/complications
Male ; Humans ; Child ; Child, Preschool ; Adolescent ; Steroids/therapeutic use ; Immunoglobulin E
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: a case report.
Autorzy:
Sabbe M; Department of Respiratory Medicine, CHU Liege, Liège, Belgium. .
Schleich F; Department of Respiratory Medicine, CHU Liege, Liège, Belgium.
Janssens P; Dermatology, Medicard, Libramont, Belgium.
Louis R; Department of Respiratory Medicine, CHU Liege, Liège, Belgium.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Jan 31; Vol. 18 (1), pp. 63. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Asthma*/drug therapy
Eosinophilia*/drug therapy
Biological Products*/therapeutic use
Anti-Asthmatic Agents*/therapeutic use
Antibodies, Monoclonal, Humanized*
Male ; Humans ; Middle Aged ; Eosinophils ; Quality of Life ; Biomarkers ; Inflammation/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs.
Autorzy:
Ridolo E; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
Barone A; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
Ottoni M; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
Peveri S; Departmental Unit of Allergology, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
Montagni M; Departmental Unit of Allergology, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy.
Nicoletta F; Department of Medicine and Surgery, University of Parma, 43121 Parma, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 30; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Eosinophilic Esophagitis*/drug therapy
Biological Products*/therapeutic use
Enteritis*
Eosinophilia*
Gastritis*
Humans ; Biological Therapy ; Biological Factors/therapeutic use
SCR Disease Name:
Eosinophilic enteropathy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities.
Autorzy:
Naharro-González S; Immunoallergy Laboratory, Immunology Department, Fundación Jimenez Díaz Health Research Institute (IIS-FJD, UAM), 28040 Madrid, Spain.
Lorente-Sorolla C; Immunoallergy Laboratory, Immunology Department, Fundación Jimenez Díaz Health Research Institute (IIS-FJD, UAM), 28040 Madrid, Spain.
Rodrigo-Muñoz JM; Immunoallergy Laboratory, Immunology Department, Fundación Jimenez Díaz Health Research Institute (IIS-FJD, UAM), 28040 Madrid, Spain.; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Valverde-Monge M; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Allergy Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Pinillos-Robles EJ; Pulmonology Unit, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Betancor D; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Allergy Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Fernández-Nieto M; Allergy Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Sánchez-Mellado D; Pulmonology Unit, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Gil-Martínez M; Immunoallergy Laboratory, Immunology Department, Fundación Jimenez Díaz Health Research Institute (IIS-FJD, UAM), 28040 Madrid, Spain.; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
Santillán-Coello JM; ENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Villacampa-Aubá JM; ENT and Cervicofacial Surgery Department, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Mahillo-Fernandez I; Department of Epidemiology, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Herrero-González A; Data Analysis Department, I Fundación Jimenez Díaz Health Research Institute (IIS-FJD, UAM), Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Perez-González A; Data Analysis Department, I Fundación Jimenez Díaz Health Research Institute (IIS-FJD, UAM), Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Rodríguez-Nieto MJ; Pulmonology Unit, Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.; Villalba General University Hospital, 28400 Madrid, Spain.
Del Pozo V; Immunoallergy Laboratory, Immunology Department, Fundación Jimenez Díaz Health Research Institute (IIS-FJD, UAM), 28040 Madrid, Spain.; CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.; Department of Medicine, Autonomous University of Madrid, 28049 Madrid, Spain.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Jan 18; Vol. 14 (1). Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Asthma*/complications
Asthma*/epidemiology
Hypertension*
Mustelidae*
Pulmonary Eosinophilia*
Dyslipidemias*/epidemiology
Pulmonary Disease, Chronic Obstructive*/epidemiology
Humans ; Animals ; Retrospective Studies ; Hospitalization
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 19023

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies